Gerard W. Barousse Jr., a director at FB Bancorp, Inc. (NASDAQ:FBLA), recently acquired 5,000 shares of the company's common stock, according to a recent SEC filing. The shares were purchased at an average price of $12.21 each, amounting to a total transaction value of approximately $61,032. Post-transaction, Barousse holds 50,000 shares directly. The transaction was conducted through a trust established for his daughter.
InvestingPro Insights
The recent insider purchase by Director Gerard W. Barousse Jr. at FB Bancorp, Inc. (NASDAQ:FBLA) aligns with several interesting financial metrics and trends highlighted by InvestingPro. As of the latest data, FBLA's stock is trading near its 52-week high, with a price that is 96.7% of its peak. This proximity to the high point suggests investor confidence, which may be bolstered by the director's decision to increase his stake.
InvestingPro data reveals that FB Bancorp has a market capitalization of $241.82 million, positioning it as a small-cap stock in the banking sector. The company's price-to-book ratio stands at 1.51, indicating that the stock is trading at a modest premium to its book value. This valuation metric could be of interest to value investors considering the banking sector.
One of the InvestingPro Tips notes that FBLA's stock generally trades with low price volatility, which may appeal to investors seeking stability. Additionally, the company's liquid assets exceed its short-term obligations, suggesting a strong balance sheet position—a crucial factor for financial institutions.
It's worth noting that FB Bancorp is not currently profitable over the last twelve months, with a negative P/E ratio of -119.85. However, the company boasts an impressive gross profit margin of 98.59% for the last twelve months as of Q3 2024, indicating efficient core operations despite the overall profitability challenges.
For investors seeking more comprehensive analysis, InvestingPro offers 6 additional tips for FB Bancorp, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.